Literature DB >> 19807322

Health utility estimation.

George W Torrance1, William Furlong, David Feeny.   

Abstract

Preference measurement techniques, like the standard gamble, time trade-off, visual analog scale, EuroQol, Health Utilities Index and Quality of Well-Being, are increasingly appearing in published studies. The scores from these instruments are variously called utilities, values or preferences. What are these concepts and do they differ? What are these instruments and what do they measure? What does a reader need to know to make sense of it all? What does a user need to know to select an appropriate approach? Read on for the answers.

Year:  2002        PMID: 19807322     DOI: 10.1586/14737167.2.2.99

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  33 in total

1.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

2.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Randomized controlled trial protocol feasibility: The Wheelchair Self-Efficacy Enhanced for Use (WheelSeeU).

Authors:  Krista L Best; William C Miller; Janice J Eng; François Routhier; Charles Goldsmith
Journal:  Can J Occup Ther       Date:  2014-12       Impact factor: 1.614

Review 4.  Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.

Authors:  Joseph P Broderick; Opeolu Adeoye; Jordan Elm
Journal:  Stroke       Date:  2017-06-16       Impact factor: 7.914

5.  Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada.

Authors:  Daria J O'Reilly; Feng Xie; Eleanor Pullenayegum; Hertzel C Gerstein; Janet Greb; Gord K Blackhouse; Jean-Eric Tarride; Jim Bowen; Ron A Goeree
Journal:  Qual Life Res       Date:  2011-01-08       Impact factor: 4.147

6.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

7.  Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.

Authors:  Louis S Matza; Kristina Secnik; Anne M Rentz; Sally Mannix; F Randy Sallee; Donald Gilbert; Dennis A Revicki
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

8.  The predictive validity of health-related quality of life measures: mortality in a longitudinal population-based study.

Authors:  Mark S Kaplan; Jean-Marie Berthelot; David Feeny; Bentson H McFarland; Saeeda Khan; Heather Orpana
Journal:  Qual Life Res       Date:  2007-11       Impact factor: 4.147

9.  Decision Analysis and Cost-effectiveness Analysis.

Authors:  Hilary F Ryder; Christine McDonough; Anna N A Tosteson; Jon D Lurie
Journal:  Semin Spine Surg       Date:  2009-12

Review 10.  Health economic assessment: a methodological primer.

Authors:  Steven Simoens
Journal:  Int J Environ Res Public Health       Date:  2009-11-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.